Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
Noosa News17 hours agoComing Soon: The Malibu Barbie Cafe Is Popping Up in Australia for the First Time, Complete with a Cocktail-Slinging Ken-Themed Bar
-
General6 hours agoWA government rolls out suite of housing assistance ahead of state budget
-
General24 hours agoChris Bowen must be sobbing over Albanese’s AI deal
-
Noosa News16 hours agoThe Latest Trailer for ‘Squid Game’ Season Three Is Here — and “No Matter How You Look at It, Life Is Just Unfair”